for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Westlaw News

GlaxoSmithKline seeks MDL for Zofran birth-defect cases

(Reuters) - GlaxoSmithKline has asked a federal judicial panel to consolidate a dozen lawsuits alleging that its anti-nausea medication Zofran can cause birth defects in children born to women who took the drug while pregnant.

In a filing with the U.S. Judicial Panel on Multidistrict Litigation on Monday, the drugmaker said the cases should be transferred to federal court in Pennsylvania, where its U.S.-based operations are headquartered.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/1Co2miN

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up